Navigation Links
Pharmaceutical Insiders with Proof of Company’s Improper Relationships: Federal Law Offers Whistleblowers Opportunity for Sizable Financial Compensation, Parker Waichman LLP Says
Date:10/22/2013

New York, New York (PRWEB) October 22, 2013

Parker Waichman LLP, a national law firm that represents whistleblowers in qui tam cases, is looking to inform potential whistleblowers in the pharmaceutical industry that if they have proof of an improper relationship between their firm and a government entity, such as a regulating agency, financial opportunities abound, courtesy of the federal government.

One recent example involving a potential unlawful relationship between a regulator and one or more pharmaceutical companies centers on a scientific panel charged with shaping the federal government’s policy for testing the safety and effectiveness of painkillers. As The Washington Post reported on Oct. 6, 2013, major pharmaceutical companies funded the panel, paying hundreds of thousands of dollars for an opportunity “to affect the thinking” of the U.S. Food and Drug Administration (FDA), according to hundreds of emails that were obtained via a public records request.

The emails show, The Washington Post noted, that the pharmaceutical companies paid as much as $25,000 to attend panel meetings. Two medical professors, Robert Dworkin of the University of Rochester and Dennis Turk of the University of Washington, organized the panel, and as The Washington Post reported, the emails mainly described their efforts at financing and organizing the group and its meetings.

The Post article further noted that the FDA has been disparaged for failing to put in place stricter precautions that might have helped the U.S. to avoid the, “epidemic of addiction to prescription drugs,” such as Oxycontin and other opioids.

Sen. Joe Manchin III has since called for an investigation into “pay to play” allegations regarding the scientific panel, The Washing Post reported on Oct. 9, 2013. In a letter to FDA Commissioner Margaret Hamburg, noted in the Oct. 9 Washington Post report, Manchin requested a list of documents be turned over to his office; the list included the names of all the companies that had paid to attend the panel’s meetings, as well as how much they paid. Also of interest, the Post article added, were any emails between the companies’ event organizers and FDA officials.

The Oct. 9 Washing Post report added that Manchin (D-W. Va.) had been pushing the FDA to place stricter limits on hydrocodone — a key ingredient in the painkillers Vicodin and Lortab — due to its, “addictive power and widespread availability.” Pharmacy companies and others have disagreed with this tact, the Post report noted, claiming that additional restrictions, “could unfairly put the drugs out of reach for patients who need them.”

In recent years many pharmaceutical employees have come forward to report fraudulent billing, illegal marketing techniques and undisclosed drug side effects. These people – known as whistleblowers – have helped the federal government recover billions of dollars obtained illegally by pharmaceutical companies. Whistleblowers have also helped save the lives of countless prescription drug and medical device users who were previously unaware of the side effects of their device or prescription.

Specifically, the Civil War-era False Claims Act provides whistleblowers with protection and the opportunity for compensation. Amendments added to the Act in 1986 helped to incentivize whistleblowers to come forward, primarily by raising the amounts that can be charged for damages and penalties; whistleblowers can be awarded millions of dollars today; between 15% and 30% of the amount recovered by the government.

Anyone who possesses proof that a pharmaceutical company has engaged in an unlawful relationship and is thereby committing fraudulent activity against the federal government is encouraged to contact us. Please view our Qui Tam page or call 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+(800) LAW-INFO
1+(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/whistleblower_FDA_panel/painkillers/prweb11256696.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... met this week to review more than eighty-nine grant submissions all vying ... emerging young scientists in the Parkinson’s field.     , The American Parkinson Disease Association ...
(Date:5/26/2017)... ... , ... Amir Qureshi, MD is the first physician in Arkansas to implant ... The Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for ... to introduce the most powerful SCS system and the only stretchable lead on the ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... premium delicatessen foods, is sharing bold recipes for Memorial Day entertaining that are ... menus. , “Boar’s Head fresh sliced meats and cheeses featured in these ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... After raising ... Antzy Top gadget will continue to be available at a discounted crowdfunding price on ... with stress wherever they are, I also wanted to bring a fidget toy to ...
(Date:5/26/2017)... ... ... Lowe acts as host and helps educate and inform the public using the “Informed” ... reconnect with America as it explores some of the best places to hike and ... inventive new place for a family vacation, and have discovered hiking. Many will agree ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... , May 4, 2017  Fortuna Fix Inc. (" ... to be the first to eliminate the need for embryonic ... cells to treat neurodegenerative diseases. Fortuna ... with Professor Michael Fehlings , MD, PhD; Father ... , MD, MPH; and Professor James Giordano , PhD. ...
(Date:5/4/2017)... Israel , May 4, 2017  DarioHealth Corp. ... mobile health and big data solutions, today announced that ... A&D Company, and STI Technologies Limited to lower diabetes ... immediately. Through STI,s innoviCares card, which is available throughout ... , DarioHealth customers will be eligible for additional savings ...
(Date:5/3/2017)...  Kalorama Information notes that transplant diagnostics is ... and this is projected to continue to 2021. ... or bone marrow transplants require histocompatibility between the ... this task. This according to a new report ... various PCR-based methodologies, Sanger sequencing and NGS used ...
Breaking Medicine Technology: